http://www.cnn.com/2006/HEALTH/02/02/birdflu.vaccine.reut/index.html

[Guest guest]

Bird flu vaccine works in mice

 

Thursday, February 2, 2006; Posted: 4:14 a.m. EST (09:14 GMT)

 

story.turkey.hospital.ap.jpg

A WHO doctor (L) shows how to correctly fit an N-95 mask in Turkey.

RELATED

• World pledges $1.9B to bird flu fight

• World Bank eyes $1B for bird flu

• EU pledges $100M to bird flu fight

• Bird flu tops Asia's 2006 concerns

• TIME.com: Lessons from Turkeyexternal link

HEALTH LIBRARY

Mayo Clinic

• Health Library

SPECIAL REPORT

• Bird flu: What you need to know

• Interactive: What is influenza?

• Health Library

• Latest news on bird flu

• Special report

YOUR E-MAIL ALERTS

Turkey

Asia

Indonesia

Health Organizations

or Create Your Own

Manage Alerts | What Is This?

 

LONDON, England (Reuters) -- Scientists have produced a vaccine against

deadly H5N1 strains of bird flu that has protected mice, using a genetic

engineering technique that can be easily scaled up for stockpiling to

prepare for a pandemic.

 

Dr Suryaprakash Sambhara, of the Centers for Disease Control and Prevention

(CDC) in Atlanta, Georgia, said it can be made much more quickly than

conventional vaccines and enough doses could be produced to protect people

at risk.

 

It is also effective against newer strains of flu and does not need an

adjuvant, or additive, to boost the immune system response.

 

"This vaccine can protect humans against newer viruses," Sambhara said in an

interview on Thursday.

 

"Our goal is to move it forward to Phase 1 clinical trials."

 

Developing a vaccine that can be easily and quickly produced is the best

hope of preventing millions of deaths from pandemic flu. Global health

officials fear the H5N1 avian flu that has spread from Asia could mutate

into a strain that could pass easily from person to person.

 

So far the virus that has killed at least 85 people since late 2003 has not

shown it is highly infectious in humans.

Feasible strategy

 

Current vaccines, which can take up to 6 months to produce, are made in

fertilized chicken eggs. Scientists estimate that 4 billion eggs would be

needed to produce enough pandemic vaccine for the up to 2 billion people

worldwide who would be at high risk.

 

Egg-based vaccines are also not useful for stockpiling because a vaccine

would have to be specific to the pandemic strain.

 

Sambhara, Dr Suresh Mittal of Purdue University in Indiana and their

colleagues genetically engineered an adenovirus, or common cold virus, to

produce a protein call haemugglutnin subtype 5 (H5HA), which is a component

of the H5N1 virus.

 

"This H5 adenovirus vaccine is an egg-independent and adjuvant-independent

strategy," said Sambhara.

 

The scientists injected one group of mice with the new vaccine and another

with a saline solution before infecting the animals with H5N1 viruses

isolated from people in 2003 and 2004.

 

The scientists, whose findings are reported online by The Lancet medical

journal, said although the vaccinated mice had low or no antibodies they did

not lose weight or die.

 

Antibodies are immune system proteins that neutralize the virus. The H5

adenovirus vaccine generated immune system cells called T cells in the mice

that attacked the strains of recent H5N1 avian influenza.

 

"It not only induces antibodies, it also induces T cells response," said

Sambhara.

 

He added that many million doses of the vaccine can be made with existing

technology.

 

"This approach is a feasible vaccine strategy against existing and newly

emerging viruses of highly pathogenic avian influenza to prepare against a

pandemic," the scientists said in the journal.